AR
IGMS

Advisory Research’s IGM Biosciences IGMS Stock Holding History

Advisory Research’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,661
Closed -$1.08M – 325
2020
Q3 		$1.08M Buy
14,661
+6,665
+83% +$395K 0.11% 165
2020
Q2 		$584K Sell
7,996
-50
-0.6% -$3.04K 0.05% 233
2020
Q1 		$452K Buy
+8,046
New +$353K 0.03% 202

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Advisory Research's IGMS Position: Q4 2020 in Review

Advisory Research sold out of IGM Biosciences (IGMS) in Q4 2020, closing a stake of 14,661 shares — an estimated $1.08M sold.

Advisory Research first reported a position in IGMS in Q1 2020 and held it in 3 quarters. The position peaked at $1.08M in Q3 2020. 107 funds tracked by Wall St. Rank hold IGMS as of Q4 2020.

  • Advisory Research reported no remaining IGM Biosciences position as of Q4 2020 after selling out during the quarter.
  • Advisory Research sold 14,661 IGM Biosciences shares in Q4 2020, an estimated $1.08M.
  • Advisory Research first reported a position in IGM Biosciences in Q1 2020 and held it in 3 quarters.
  • Advisory Research's IGM Biosciences position peaked at $1.08M in Q3 2020.
  • 107 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.